Single-use Bioreactors Market worth 1,085.7 Million USD by 2021

By -

The single-use bioreactors market is projected to reach USD 1,085.7 Million by 2021 from USD 408.4 Million in 2016, growing at a CAGR of 21.6% during the forecast period of 2016 to 2021.

(EMAILWIRE.COM, April 26, 2017 ) Browse 115 market data Tables and 55 Figures spread through 148 Pages and in-depth TOC on "Single-use Bioreactor Market"
http://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html
Early buyers will receive 10% customization on this report.

Improved returns on investment for small companies and startups, and reduced complexity of automation are the major factors driving the adoption of single-use bioreactors. On the other hand, regulatory concerns related to SUBs and issues regarding leachables and extractables are the major factors restraining the growth of this market.

The single-use bioreactors market is segmented on the basis of product type, cell type, technology, application, end user, and region. Based on product type, the market is segmented into monoclonal antibodies, vaccines, gene-modified cells, recombinant proteins, stem cells, and other products (growth factors, interferons, and antisense DNA & RNA).

Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=49113750

The monoclonal antibodies segment is expected to dominate this market primarily due to the rising demand for monoclonal antibodies in medical treatments owing to their high therapeutic efficiency.

On the basis of cell type, the single-use bioreactors market is categorized into mammalian cells, bacteria, yeast, and other cells (insect cells and plant cells). In 2016, the mammalian cells segment is expected to account for the largest share of the single-use bioreactors market owing to the increasing application of these cells in biologics manufacturing as a result of the highly mechanized metabolic machinery required for complex biomolecules.

Based on technology, the market is segmented into wave-induced motion SUBs, stirred SUBs, single-use bubble column bioreactors, and other technologies.

Request for the Customization of this Report@
http://www.marketsandmarkets.com/requestCustomization.asp?id=49113750

The wave-induced motion SUBs segment is expected to account for the largest market share in 2016. Growth in this segment can be attributed to the advantages of wave-induced motion SUBs, such as high flexibility and shorter lead times.

The application segments in the single-use bioreactors market include bioproduction processes, process development, and research & development. The bioproduction processes segment is expected to account for the largest market share in 2016. Considering advantages such as low investments and easy implementation, single-use bioreactors are increasingly being adopted in bioproduction processes. This is the major factor responsible for the large share of this application segment.

The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech SA (France), Merck Millipore (Germany), GE Healthcare (U.K.), Danaher Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more